Optimizing animal models of autoimmune encephalitis using active immunization

被引:4
|
作者
Linnoila, Jenny [1 ,2 ]
Motlagh, Negin Jalali [3 ,4 ]
Jachimiec, Grace [2 ]
Lin, Chih-Chung Jerry [2 ]
Kullenberg, Enrico [3 ,4 ]
Wojtkiewicz, Gregory [4 ]
Tanzi, Rudolph [2 ]
Chen, John W. [3 ,4 ]
机构
[1] Massachusetts Gen Hosp MGH, Dept Neurol, Div Neuroimmunol & Neuroinfect Dis, Boston, MA 02114 USA
[2] Massachusetts Gen Hosp MGH, McCance Ctr Brain Hlth, Dept Neurol, Genet & Aging Res Unit, Boston, MA 02114 USA
[3] Massachusetts Gen Hosp MGH, Inst Innovat Imaging, Dept Radiol, Boston, MA USA
[4] Massachusetts Gen Hosp MGH, Ctr Syst Biol, Boston, MA USA
来源
FRONTIERS IN IMMUNOLOGY | 2023年 / 14卷
关键词
autoimmune encephalitis; NMDA receptor encephalitis; mouse model; active immunization; experimental autoimmune encephalomyelitis (EAE); NMDA-RECEPTOR ENCEPHALITIS; MYELOPEROXIDASE; MICE;
D O I
10.3389/fimmu.2023.1177672
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background and objectivesEncephalitis is a devastating neurologic disorder with high morbidity and mortality. Autoimmune causes are roughly as common as infectious ones. N-methyl-D-aspartic acid receptor (NMDAR) encephalitis (NMDARE), characterized by serum and/or spinal fluid NMDAR antibodies, is the most common form of autoimmune encephalitis (AE). A translational rodent NMDARE model would allow for pathophysiologic studies of AE, leading to advances in the diagnosis and treatment of this debilitating neuropsychiatric disorder. The main objective of this work was to identify optimal active immunization conditions for NMDARE in mice. MethodsFemale C57BL/6J mice aged 8 weeks old were injected subcutaneously with an emulsion of complete Freund's adjuvant, killed and dessicated Mycobacterium tuberculosis, and a 30 amino acid peptide flanking the NMDAR GluN1 subunit N368/G369 residue targeted by NMDARE patients' antibodies. Three different induction methods were examined using subcutaneous injection of the peptide emulsion mixture into mice in 1) the ventral surface, 2) the dorsal surface, or 3) the dorsal surface with reimmunization at 4 and 8 weeks (boosted). Mice were bled biweekly and sacrificed at 2, 4, 6, 8, and 14 weeks. Serum and CSF NMDAR antibody titer, mouse behavior, hippocampal cell surface and postsynaptic NMDAR cluster density, and brain immune cell entry and cytokine content were examined. ResultsAll immunized mice produced serum and CSF NMDAR antibodies, which peaked at 6 weeks in the serum and at 6 (ventral and dorsal boosted) or 8 weeks (dorsal unboosted) post-immunization in the CSF, and demonstrated decreased hippocampal NMDAR cluster density by 6 weeks post-immunization. In contrast to dorsally-immunized mice, ventrally-induced mice displayed a translationally-relevant phenotype including memory deficits and depressive behavior, changes in cerebral cytokines, and entry of T-cells into the brain at the 4-week timepoint. A similar phenotype of memory dysfunction and anxiety was seen in dorsally-immunized mice only when they were serially boosted, which also resulted in higher antibody titers. DiscussionOur study revealed induction method-dependent differences in active immunization mouse models of NMDARE disease. A novel ventrally-induced NMDARE model demonstrated characteristics of AE earlier compared to dorsally-induced animals and is likely suitable for most short-term studies. However, boosting and improving the durability of the immune response might be preferred in prolonged longitudinal studies.
引用
收藏
页数:15
相关论文
共 50 条
  • [31] Mycophenolate mofetil in animal models of autoimmune disease
    Zandman-Goddard, G
    Shoenfeld, Y
    LUPUS, 2005, 14 : S12 - S16
  • [32] ANIMAL-MODELS OF AUTOIMMUNE HEMOLYTIC DISEASE
    BULL, RW
    SEMINARS IN HEMATOLOGY, 1976, 13 (04) : 349 - 353
  • [33] Lessons on autoimmune diabetes from animal models
    Yang, Yang
    Santamaria, Pere
    CLINICAL SCIENCE, 2006, 110 (06) : 627 - 639
  • [34] Genetics of autoimmune diseases in humans and in animal models
    Morahan, G
    Morel, L
    CURRENT OPINION IN IMMUNOLOGY, 2002, 14 (06) : 803 - 811
  • [35] Animal models in autoimmune disease in immunotoxicity assessment
    Farine, JC
    TOXICOLOGY, 1997, 119 (01) : 29 - 35
  • [36] Animal Models for Autoimmune Hepatitis: Are Current Models Good Enough?
    Christen, Urs
    Hintermann, Edith
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [37] Optimizing Animal Models to Examine Cardiovascular Biomaterial Hemocompatibility
    Anderson, D. E.
    Cutiongco, M. F.
    Pohan, G.
    Yim, E. K.
    Hinds, M. T.
    TISSUE ENGINEERING PART A, 2016, 22 : S155 - S155
  • [38] The role of NKT cells in animal models of autoimmune hepatitis
    Dennert, Gunther
    Aswad, Fred
    CRITICAL REVIEWS IN IMMUNOLOGY, 2006, 26 (05) : 453 - 473
  • [39] Ovarian autoimmune disease: clinical concepts and animal models
    Bryce D Warren
    William K Kinsey
    Lynda K McGinnis
    Lane K Christenson
    Susmita Jasti
    Anne M Stevens
    Brian K Petroff
    Margaret G Petroff
    Cellular & Molecular Immunology, 2014, 11 : 510 - 521
  • [40] Animal models for predicting autoimmune responses to biomaterials.
    Lightfoote, MM
    Bushar, G
    Greenfield, W
    Langone, JJ
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1997, 99 (01) : 787 - 787